Industry analyst anticipates upturn in U.S. warehouse construction for 2026
The worse may be over for the U.S. warehouse market, according to research published today by the market intelligence firm Interact Analysis. Senior analyst Matthieu Kulezak writes that the market bottomed out in 2025 and is now slowly recovering, benefiting from easing economic uncertainty and steady e-commerce demand.According to Interact Analysis, the number of...
Outsourcing complexity
Managing logistics operations in-house is often the easiest way to ensure that your supply chain feels like an extension of your brand. But that level of control and quality is hard to sustain as a company expands: More volume means more complexity, and many growing companies find themselves looking for alternative, cost-effective solutions to manage that growth.That’s...
What Should We Learn From How Attackers Leveraged AI in 2025?
Old Playbook, New Scale: While defenders are chasing trends, attackers are optimizing the basics The security industry loves talking about “new” threats. AI-powered attacks. Quantum-resistant encryption. Zero-trust architectures. But looking around, it seems like the most effective attacks in 2025 are pretty much the same as they were in 2015. Attackers are...
New Advanced Linux VoidLink Malware Targets Cloud and container Environments
Cybersecurity researchers have disclosed details of a previously undocumented and feature-rich malware framework codenamed VoidLink that’s specifically designed for long-term, stealthy access to Linux-based cloud environments According to a new report from Check Point Research, the cloud-native Linux malware framework comprises an array of custom loaders, implants,...![[Webinar] Securing Agentic AI: From MCPs and Tool Access to Shadow API Key Sprawl](https://theindustryexpert.com/wp-content/uploads/2026/01/ai-agent-800x417.jpg)
[Webinar] Securing Agentic AI: From MCPs and Tool Access to Shadow API Key Sprawl
AI agents are no longer just writing code. They are executing it. Tools like Copilot, Claude Code, and Codex can now build, test, and deploy software end-to-end in minutes. That speed is reshaping engineering—but it’s also creating a security gap most teams don’t see until something breaks. Behind every agentic workflow sits a layer few organizations are actively securing:...
Visualizing the invisible: 5 recent breakthroughs in microscopy
Microscopy is an imaging technique that enables us to see a world that would otherwise be invisible to us. Once upon a time, visualizing cells, microbes and other entities not perceptible to the naked eye was impossible. Then came the advent of microscopy in the 16th century, which brought the minuscule world around us into sharper focus. Microscopy has come a long way in...
A new explanation for how bacteria swim
Original story from the Simons Foundation (NY, USA). Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of biology’s most intensively studied molecular machines. Bacteria move through liquids using propellerlike tails called flagella, which alternate between clockwise and counterclockwise rotation. For...
Earthworms vs antibiotic resistance: an unexpected ally?
Original story from Shenyang Agricultural University (China). Earthworms could become unexpected allies in the global fight against antibiotic resistance by helping farmers turn manure into safer, high-value organic fertilizer through a process called vermicomposting. Researchers report that this low-energy, nature-based technology can remove antibiotic resistance genes far...
The Salary of a Chief Security Officer
The 24th annual Security and Compliance Compensation report gives industry professionals insight into what their peers are earning. Continue reading →
Security Leaders Discuss FBI Warning: North Korea Exploiting QR Codes
What security leaders are saying about the recent FBI warning. Continue reading →
JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to appease jittery investors. Continue reading →
